Indocyanine green-mediated photothrombosis with and without intravitreal triamcinolone acetonide for subfoveal choroidal neovascularization in age-related macular degeneration: A pilot study

Retina

Volumn 25, Issue 6, 2005, Pages 719-726

  Arevalo, J Fernando ^a   Mendoza, Arístides J ^a   Fernández, Carlos F ^a  

^a Clinica Oftalmologica Centro Caracas   (Venezuela)

Author keywords

AMD; Choroidal neovascularization; ICG; IMP; Indocyanine green; Intravitreal; Photothrombosis; Triamcinolone acetonide

Indexed keywords

INDOCYANINE GREEN; TRIAMCINOLONE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; FEMALE; FLUORESCENCE ANGIOGRAPHY; FOLLOW UP; HUMAN; MALE; MULTICENTER STUDY; OPTICAL COHERENCE TOMOGRAPHY; PHOTOACTIVATION; PILOT STUDY; RANDOMIZATION; REGRESSION ANALYSIS; RETINA MACULA AGE RELATED DEGENERATION; SUBRETINAL FLUID; SUBRETINAL NEOVASCULARIZATION; THROMBOSIS; TREATMENT OUTCOME; VISUAL ACUITY;

AGED; AGED, 80 AND OVER; CHOROIDAL NEOVASCULARIZATION; COLORING AGENTS; COMBINED MODALITY THERAPY; EMBOLIZATION, THERAPEUTIC; FEASIBILITY STUDIES; FEMALE; FLUORESCEIN ANGIOGRAPHY; FOVEA CENTRALIS; GLUCOCORTICOIDS; HUMANS; INDOCYANINE GREEN; INJECTIONS; MACULAR DEGENERATION; MALE; MIDDLE AGED; PILOT PROJECTS; PROSPECTIVE STUDIES; TOMOGRAPHY, OPTICAL COHERENCE; TRIAMCINOLONE ACETONIDE; VISUAL ACUITY; VITREOUS BODY;

EID: 24344508134     PISSN: 0275004X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006982-200509000-00006     Document Type: Article

References (39)

1. Klein R, Klein BE, Linton KL. Prevalence of age-related maculopathy. The Beaver Dam Eye Study. Ophthalmology 1992;99:933-943.
2. Klein R, Klein BE, Jensen SC, Meuer SM. The five-year incidence and progression of age-related maculopathy: the Beaver Dam Eye Study. Ophthalmology 1997;104:7-21.
3. Macular Photocoagulation Study Group. Argon laser photocoagulation for neovascular maculopathy: five years results for randomized clinical trials. Arch Ophthalmol 1991;109:1109-1114.
4. Macular Photocoagulation Study Group. Krypton laser photocoagulation for neovascular lesions of age-related macular degeneration: results for randomized clinical trials. Arch Ophthalmol 1990;108:816-824.
5. Bressler NM, Bressler SB. Photodynamic therapy with verteporfin (Visudyne): impact on ophthalmology and visual sciences. Invest Ophthalmol Vis Sci 2000;41:624-628.
6. Sharma S, Brown GC, Brown MM, Hollands H, Shah GK. The cost-effectiveness of photodynamic therapy for fellow eyes with subfoveal choroidal neovascularization secondary to age-related macular degeneration. Ophthalmology 2001;108:2051-2059.
7. Preclinical and phase 1A clinical evaluation of an anti-VEGF pegylated aptamer (EYE001) for the treatment of exudative age-related macular degeneration. Retina 2002;22:143-152.
8. Bressler NM. Submacular surgery. Are randomized trials necessary? Arch Ophthalmol 1995;113:1557-1560.
9. Finger PT, Berson A, Sherr D, Riley R, Balkin RA, Bosworth JL. Radiation therapy for subretinal neovascularization. Ophthalmology 1996;103:878-889.
10. Miller JW, Stinson WG, Folkman J. Regression of experimental iris neovascularization with systemic alpha-interferon. Ophthalmology 1993;100:9-14.
11. Costa RA, Farah ME, Cardillo JA, Belfort R Jr. Photodynamic therapy with indocyanine green for occult subfoveal choroidal neovascularization caused by age-related macular degeneration. Curr Eye Res 2001;23:271-275.
12. Costa RA, Farah ME, Freymuller E, Morales PH, Smith R, Cardillo JA. Choriocapillaris photodynamic therapy using indocyanine green. Am J Ophthalmol 2001;132:557-565.
13. Costa R, Scapucin L, Moraes N, et al. Indocyanine green-mediated photothrombosis as a new technique of treatment for persistent central serous chorioretinopathy. Curr Eye Res 2002;25:287-297.
14. Costa RA, Meirelles RL, Cardillo JA, Abrantes ML, Farah ME. Retinal capillary hemangioma treatment by indocyanine green-mediated photothrombosis. Am J Ophthalmol 2003;135:395-398.
15. Ishibashi T, Miki K, Sorgente N, Patterson R, Ryan SJ. Effects of intravitreal administration of steroids on experimental subretinal neovascularization in the subhuman primate. Arch Ophthalmol 1985;103:708-711.
16. Danis RP, Bingaman DP, Yang Y, Ladd B. Inhibition of preretinal and optic nerve head neovascularization in pigs by intravitreal triamcinolone acetonide. Ophthalmology 1996;103:2099-2104.
17. Tano Y, Chandler D, Machemer R. Treatment of intraocular proliferation with intravitreal injection of triamcinolone acetonide. Am J Ophthalmol 1980;90:810-816.
18. Antoszyk AN, Gottlieb JL, Machemer R, Hatchell DL. The effects of intravitreal triamcinolone acetonide on experimental pre-retinal neovascularization. Graefes Arch Clin Exp Ophthalmol 1993;231:34-40.
19. Folkman J, Ingber DE. Angiostatic steroids. Method of discovery and mechanism of action. Ann Surg 1987;206:374-383.
20. Penfold PL. Intravitreal triamcinolone in recurrence of choroidal neovascularization. Br J Ophthalmol 2002;86:600-601.
21. Penfold PL, Gyory JF, Hunyor AB, Billson FA. Exudative macular degeneration and intravitreal triamcinolone. A pilot study. Aust NZ J Ophthalmol 1995;23:293-298.
22. Navajas EV, Costa RA, Farah ME, Cardillo JA, Bonomo PP. Indocyanine green-mediated photothrombosis combined with intravitreal triamcinolone for the treatment of choroidal neovascularization in serpiginous choroiditis. Eye 2003;17:563-566.
23. Spaide RF, Sorenson J, Maranan L. Combined photodynamic therapy with verteporfin and intravitreal triamcinolone acetonide for choroidal neovascularization. Ophthalmology 2003;110:1517-1525.
24. Treatment of Age-related Macular Degeneration with Photodynamic therapy Study Group. Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin. Arch Ophthalmol 1999;117:1329-1345.
25. VIP Study Group. Verteporfin therapy of subfoveal choroidal neovascularization in age-related macular degeneration: two-year results of a randomized clinical trial including lesions with occult with no classic choroidal neovascularization verteporfin in photodynamic therapy report 2. Am J Ophthalmol 2001;131:541-560.
26. Ghazi NG, Jabbour NM, De La Cruz ZC, Green WR. Clinicopathologic studies of age-related macular degeneration with classic subfoveal choroidal neovascularization treated with photodynamic therapy. Retina 2001;21:478-486.
27. Schnurrbusch UE, Welt K, Horn LC, Wiedemann P, Wolf S. Histological findings of surgically excised choroidal neovascular membranes after photodynamic therapy. Br J Ophthalmol 2001;85:1086-1091.
28. Moshfeghi DM, Kaiser PK, Grossniklaus HE, et al. Clinicopathologic study after submacular removal of choroidal neovascular membranes treated with verteporfin ocular photodynamic therapy. Am J Ophthalmol 2003;135:343-350.
29. Schmidt-Erfurth U, Laqua H, Schlotzer-Schrehard U, Viestenz A, Naumann GO. Histopathological changes following photodynamic therapy in human eyes. Arch Ophthalmol 2002;120:835-844.
30. Fox I, Brooker G, Heseltine D, Essex H, Wood E. New dyes for continuous recording of dilution curves in whole blood independent of variations in blood oxygen saturation. Am J Physiol 1956;187:599-606.
31. Flower R, Hochheimer B. Indocyanine green dye fluorescence and infrared absorption choroidal angiography performed simultaneously with fluorescein angiography. Johns Hopkins Med J 1976;138:33-42.
32. Baumler W, Abels C, Karrer S, et al. Photo-oxidative killing infrared light. Br J Cancer 1999;80:360-363.
33. Reichel E, Puliafito CA, Duker JS, Guyer DR. Indocyanine green dye-enhanced diode laser photocoagulation of poorly defined subfoveal choroidal neovascularization. Ophthalmic Surg 1994;25:195-201.
34. Reichel E, Berrocal A, Ip M, et al. Transpupillary thermotherapy of occult subfoveal choroidal neovascularization in patients with age-related macular degeneration. Ophthalmology 1999;106:1908-1914.
35. Machemer R, Sugita G, Tano Y. Treatment of intraocular proliferations with intravitreal steroids. Trans Am Ophthalmol Soc 1979;77:171-180.
36. Danis RP, Ciulla TA, Pratt LM, Anliker W. Intravitreal triamcinolone acetonide in exudative age-related macular degeneration. Retina 2000;20:244-250.
37. Challa JK, Gillies MC, Penfold PL, Gyory JF, Hunyor AB, Billson FA. Exudative macular degeneration and intravitreal triamcinolone: 18 month follow up. Aust NZ J Ophthalmol 1998;26:277-281.
38. Jonas JB, Kreissig I, Degenring R. Intraocular pressure after intravitreal injection of triamcinolone acetonide: Br J Ophthalmol 2003;87:24-27.
39. Jonas JB, Kreissig I, Hugger P, Sauder G, Panda-Jonas S, Degenring R. Intravitreal triamcinolone acetonide for exudative age related macular degeneration. Br J Ophthalmol 2003;87:462-468.